BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37739137)

  • 21. Focal cortical dysplasia: a practical guide for neurologists.
    Balestrini S; Barba C; Thom M; Guerrini R
    Pract Neurol; 2023 Aug; 23(4):293-302. PubMed ID: 36823117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial.
    Blümcke I; Coras R; Busch RM; Morita-Sherman M; Lal D; Prayson R; Cendes F; Lopes-Cendes I; Rogerio F; Almeida VS; Rocha CS; Sim NS; Lee JH; Kim SH; Baulac S; Baldassari S; Adle-Biassette H; Walsh CA; Bizzotto S; Doan RN; Morillo KS; Aronica E; Mühlebner A; Becker A; Cienfuegos J; Garbelli R; Giannini C; Honavar M; Jacques TS; Thom M; Mahadevan A; Miyata H; Niehusmann P; Sarnat HB; Söylemezoglu F; Najm I
    Epilepsia; 2021 Jun; 62(6):1416-1428. PubMed ID: 33949696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
    Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
    Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of brain somatic variation in epilepsy-associated developmental lesions.
    Bedrosian TA; Miller KE; Grischow OE; Schieffer KM; LaHaye S; Yoon H; Miller AR; Navarro J; Westfall J; Leraas K; Choi S; Williamson R; Fitch J; Kelly BJ; White P; Lee K; McGrath S; Cottrell CE; Magrini V; Leonard J; Pindrik J; Shaikhouni A; Boué DR; Thomas DL; Pierson CR; Wilson RK; Ostendorf AP; Mardis ER; Koboldt DC
    Epilepsia; 2022 Aug; 63(8):1981-1997. PubMed ID: 35687047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
    Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Frontal Lobe Epilepsy: A New Clinico-Pathological Entity.
    Schurr J; Coras R; Rössler K; Pieper T; Kudernatsch M; Holthausen H; Winkler P; Woermann F; Bien CG; Polster T; Schulz R; Kalbhenn T; Urbach H; Becker A; Grunwald T; Huppertz HJ; Gil-Nagel A; Toledano R; Feucht M; Mühlebner A; Czech T; Blümcke I
    Brain Pathol; 2017 Jan; 27(1):26-35. PubMed ID: 26748554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
    Lim JS; Lee JH
    BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathological work-up of focal cortical dysplasias using the new ILAE consensus classification system - practical guideline article invited by the Euro-CNS Research Committee.
    Blümcke I; Mühlebner A
    Clin Neuropathol; 2011; 30(4):164-77. PubMed ID: 21726501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
    Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
    Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
    Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C
    J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Challenge of Somatic Variants in Focal Cortical Dysplasia.
    Jesus-Ribeiro J; Pires LM; Ribeiro IP; Rebelo O; Pereira R; Sales F; Santana I; Freire A; Melo JB
    Innov Clin Neurosci; 2023; 20(10-12):35-39. PubMed ID: 38193103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR pathway activation in focal cortical dysplasia.
    Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
    D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
    Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline and somatic mutations in the
    Møller RS; Weckhuysen S; Chipaux M; Marsan E; Taly V; Bebin EM; Hiatt SM; Prokop JW; Bowling KM; Mei D; Conti V; de la Grange P; Ferrand-Sorbets S; Dorfmüller G; Lambrecq V; Larsen LH; Leguern E; Guerrini R; Rubboli G; Cooper GM; Baulac S
    Neurol Genet; 2016 Dec; 2(6):e118. PubMed ID: 27830187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI of focal cortical dysplasia.
    Urbach H; Kellner E; Kremers N; Blümcke I; Demerath T
    Neuroradiology; 2022 Mar; 64(3):443-452. PubMed ID: 34839379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal cortical dysplasias in temporal lobe epilepsy surgery: Challenge in defining unusual variants according to the last ILAE classification.
    Martinoni M; Marucci G; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Giulioni M
    Epilepsy Behav; 2015 Apr; 45():212-6. PubMed ID: 25812941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Jha R; Kurup A; Kovilapu UB; Ranjan R; Sondhi V
    Brain Dev; 2022 Feb; 44(2):166-172. PubMed ID: 34756499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
    Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
    Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the
    Barba C; Blumcke I; Winawer MR; Hartlieb T; Kang HC; Grisotto L; Chipaux M; Bien CG; Heřmanovská B; Porter BE; Lidov HGW; Cetica V; Woermann FG; Lopez-Rivera JA; Canoll PD; Mader I; D'Incerti L; Baldassari S; Yang E; Gaballa A; Vogel H; Straka B; Macconi L; Polster T; Grant GA; Krsková L; Shin HJ; Ko A; Crino PB; Krsek P; Lee JH; Lal D; Baulac S; Poduri A; Guerrini R;
    Neurology; 2023 Jan; 100(5):e528-e542. PubMed ID: 36307217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.